Ander Chapartegui Arias

PhD chemist specialized in solid-state characterization and developability for small-molecule drug development. Experienced in salt, polymorph, crystallization, dissolution, and solubility studies using automated high-throughput workflows. Strong background in LC/HPLC, analytical method development, data interpretation, troubleshooting, and cross-functional collaboration. Focused on robust workflows, quality-driven documentation, and translating solid-state insights into development decisions.

Installed automation platforms across Europe; trained users for optimal performance. Supported workflow design, customization, and troubleshooting. Applied CAPA and RCA to document issues in MS Office/Salesforce. Led DoE and method validation. Ensured GMP compliance with QA. Managed global projects, scope, and clients. Improved templates and processes. Collaborated with Roche, Pfizer, BioNTech, BI, Solvias, Lonza. Modified/troubleshot Python. Met deadlines under pressure.

Designed antibody-ZIF conjugates for ELISA using fluorescent MOFs. Developed pyrene-functionalized ZIF-90 for phthalate detection via quenching. Created novel HPLC methods for MOF analysis. Skilled in NMR, XRD, UV-Vis, and method development. Used Schiff base chemistry for MOF functionalization. Specialized in analytical/organic chemistry and materials science. Proficient in GLP, nanotech, immunoassays, chromatography, spectroscopy, ELISA, and scientific troubleshooting.

Performed QC on finished products and daily analyses under GMP. Ensured compliance with GMP, REACH, ADR. Developed two new products and reformulated two others in 3 months. Maintained SDS and labels per REACH/CLP; authored two SDS. Supported ISO 9001 QMS implementation. Conducted internal and certification audits (Bureau Veritas). Gained deep understanding of industrial chemical processes. Skilled in QC, R&D, REACH, CLP, ISO 9001, and analytical chemistry.